GAH and Tenacia announce a China commercialization partnership for ZTALMY, the first approved therapy for CDKL5 deficiency disorder.
A Cincinnati-based technology company plans to commercialize its technology creating 3D models of X-rays and MRI scans for ...
Inferact’s founding team includes computer science professor and Databricks co-founder Ion Stoica. He is currently the ...
Novel embolic device designed to obstruct or reduce blood flow, Funded by Strategic Investor. DENVER, Oct. 24, 2025 /PRNewswire/ -- Polyembo, a privately held medical device company founded to develop ...
Please provide your email address to receive an email when new articles are posted on . A Boston-area developer of brain-computer interface technology and a Canadian biotech firm have announced a ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) a global leader in life science research and clinical diagnostics products, today announced a collaboration agreement with Oncocyte Corporation (Nasdaq ...
On November 12, 2025, Sandoz announced a licensing agreement with EirGenix to commercialize EG1206A (pertuzumab), a proposed biosimilar of Genentech’s PERJETA® (pertuzumab). Under the terms of the ...
Please provide your email address to receive an email when new articles are posted on . Povorcitinib is a selective oral Janus kinase 1 inhibitor. China Medical System Holding Limited now has the ...
Milan, 29 January 2026 - Recordati today announced that it has entered into a collaboration and license agreement with Moderna to develop and commercialize worldwide mRNA-3927, an ...
LG Energy Solution is gearing up to commercialize a cutting-edge battery manufacturing technology that has so far evaded Tesla. It is positioning itself to intensify competition against its Chinese ...
Midtown-based drug discovery startup GRIN Therapeutics has reached a deal with Angelini Pharma to commercialize its signature epilepsy treatment drug outside of North America. The companies announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results